Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Heart Lung Transplant ; 31(5): 443-7, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22078821

RESUMO

INTRODUCTION: Identification of anti-human leukocyte antigen (HLA) antibodies by single-antigen beads (SAB) allows for prediction of donor-specific crossmatches (virtual crossmatches), thus facilitating the allocation of organs from deceased donors. However, the clinical relevance of HLA antibodies identified by SAB has been less than clear. This study demonstrates that sera from cardiac transplant candidates with a ventricular assist device (VAD) or infection may contain clinically irrelevant antibodies that bind to the beads but not to lymphocytes. METHODS: Investigated were 5 cardiac transplant candidates (3 with VAD, all with infections, and 1 retransplant) with positive HLA antibodies detected by SAB, but negative by cytotoxicity. To determine clinical relevance of the antibodies, flow cytometric crossmatches (FCXM) were performed. Untreated beads and elution buffer-treated beads to dissociate the ß-2 microglobulin and the peptide from the heavy chain were used. RESULTS: The virtual crossmatch data were compared with data from actual FCXMs. Of 40 T-cell and B-cell FCXM, SAB-identified HLA antibodies were predictive for only 1 T-cell and 9 B-cell FCXM outcomes. Patients' sera contained a mixture of antibodies directed against cryptic epitopes on the heavy chain and exposed epitopes. The mean fluorescence intensity of antibodies varied from 1,040 to 11,000. CONCLUSIONS: Sera from cardiac transplant candidates with or without VAD may contain natural antibodies that do not bind to intact antigens on the cell surface. Therefore, great care must be exercised before denying a life-saving transplant to these patients simply on the basis of SAB results.


Assuntos
Anticorpos/sangue , Tipagem e Reações Cruzadas Sanguíneas/métodos , Antígenos HLA/imunologia , Transplante de Coração/imunologia , Coração Auxiliar , Linfócitos B/imunologia , Citometria de Fluxo , Humanos , Infecções/imunologia , Estudos Retrospectivos , Linfócitos T/imunologia , Infecção dos Ferimentos/imunologia
2.
Cardiol Rev ; 11(1): 41-4, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12493135

RESUMO

Atrial Myxomas are benign primary tumors of the heart, arising mainly from the left atrium. Clinical signs and symptoms produced by atrial myxomas may be non-specific or result in mechanical obstruction of cardiac function, arrhythmias, and embolization. The authors present a case of a 60-year-old woman who developed total left hemiparesis resulting from left atrial myxoma embolization causing complete occlusion of the right middle cerebral artery.


Assuntos
Átrios do Coração , Neoplasias Cardíacas/diagnóstico , Mixoma/diagnóstico , Células Neoplásicas Circulantes , Paresia/diagnóstico , Infarto Cerebral/etiologia , Ecocardiografia , Feminino , Átrios do Coração/diagnóstico por imagem , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Artéria Cerebral Média/diagnóstico por imagem , Artéria Cerebral Média/patologia , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA